Tolerance mechanisms and recent progress

Transplantation Proceedings

Volumn 36, Issue 2 SUPPL., 2004, Pages S561-S569

  Chan, C ^a   Lechler, R I ^a   George, A J T ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN;

ALLOGRAFT; ANTIGEN EXPRESSION; DENDRITIC CELL; EPITHELIUM CELL; HUMAN; IMMUNITY; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; THYMOCYTE;

EID: 1642373911     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.01.019     Document Type: Article

References (119)

1. Billingham R.E., Brent L., Medawar P.B. Actively acquired tolerance of foreign cells. Nature. 172:1953;603.
2. Anderson G., Partington K.M., Jenkinson E.J. Differential effects of peptide diversity and stromal cell type in positive and negative selection in the thymus. J Immunol. 161:1998;6599.
3. Kyewski B., Derbinski J., Gotter J., et al. Promiscuous gene expression and central T-cell tolerance more than meets the eye. Trends Immunol. 23:2002;364.
4. Farr A.G., Rudensky A. Medullary thymic epithelium a mosaic of epithelial "self"? J Exp Med. 188:1998;1.
5. Derbinski J., Schulte A., Kyewski B., et al. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol. 2:2001;1032.
6. Farr A.G., Dooley J.L., Erickson M. Organization of thymic medullary epithelial heterogeneity implications for mechanisms of epithelial differentiation. Immunol Rev. 189:2002;20.
7. Heino M., Peterson P., Kudoh J., et al. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla. Biochem Biophys Res Commun. 257:1999;821.
8. Zuklys S., Balciunaite G., Agarwal A., et al. Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J Immunol. 165:2000;1976.
9. Liston A., Lesage S., Wilson J., et al. Aire regulates negative selection of organ-specific T cells. Nat Immunol. 4:2003;350.
10. Papiernik M., de Moraes M.L., Pontoux C., et al. Regulatory CD4 T cells expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol. 10:1998;371.
11. Itoh M., Takahashi T., Sakaguchi N., et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol. 162:1999;5317.
12. Bensinger S.J., Bandeira A., Jordan M.S., et al. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J Exp Med. 194:2001;427.
13. Jordan M.S., Boesteanu A., Reed A.J., et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol. 2:2001;301.
14. Pacholczyk R., Kraj P., Ignatowicz L. Peptide specificity of thymic selection of CD4+CD25+ T cells. J Immunol. 168:2002;613.
15. Dieckmann D., Plottner H., Berchtold S., et al. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med. 193:2001;1303.
16. Ng W.F., Duggan P.J., Ponchel F., et al. Human CD4(+)CD25(+) cells a naturally occurring population of regulatory T cells. Blood. 98:2001;2736.
17. Jonuleit H., Schmitt E., Stassen M., et al. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med. 193:2001;1285.
18. Levings M.K., Sangregorio R., Roncarolo M.G. Human cd25(+)cd4(+) t regulatory cells suppress naíve and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med. 193:2001;1295.
19. Sykes M. Mixed chimerism and transplant tolerance. Immunity. 14:2001;417.
20. Kawai T., Poncelet A., Sachs D.H., et al. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation. 68:1999;1767.
21. Spitzer T.R., Delmonico F., Tolkoff-Rubin N., et al. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation. 68:1999;480.
22. Duncan S.R., Capetanakis N.G., Lawson B.R., et al. Thymic dendritic cells traffic to thymi of allogeneic recipients and prolong graft survival. J Clin Invest. 109:2002;755.
23. Fandrich F., Lin X., Chai G.X., et al. Preimplantation-stage stem cells induce long- term allogeneic graft acceptance without supplementary host conditioning. Nat Med. 8:2002;171.
24. Bouneaud C., Kourilsky P., Bousso P. Impact of negative selection on the T cell repertoire reactive to a self-peptide a large fraction of T cell clones escapes clonal deletion. Immunity. 13:2000;829.
25. Kamath A.T., Henri S., Battye F., et al. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood. 100:2002;1734.
26. Huang F.P., Platt N., Wykes M., et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med. 191:2000;435.
27. Scheinecker C., McHugh R., Shevach E.M., et al. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J Exp Med. 196:2002;1079.
28. Vermaelen K.Y., Carro-Muino I., Lambrecht B.N., et al. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J Exp Med. 193:2001;51.
29. Lechler R., Ng W.F., Steinman R.M. Dendritic cells in transplantation - friend or foe? Immunity. 14:2001;357.
30. Steinman R.M., Nussenzweig M.C. Avoiding horror autotoxicus the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A. 99:2002;351.
31. Jonuleit H., Schmitt E., Schuler G., et al. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med. 192:2000;1213.
32. Dhodapkar M.V., Steinman R.M., Krasovsky J., et al. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med. 193:2001;233.
33. Lutz M.B., Suri R.M., Niimi M., et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol. 30:2000;1813.
34. Lutz M.B., Schuler G. Immature, semi-mature and fully mature dendritic cells which signals induce tolerance or immunity? Trends Immunol. 23:2002;445.
35. Wilson NS, El-Sukkari D, Belz GT, et al: Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 2003
36. Veeraswamy R.K., Cella M., Colonna M., et al. Dendritic cells process and present antigens across a range of maturation states. J Immunol. 170:2003;5347.
37. Albert M.L., Jegathesan M., Darnell R.B. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat Immunol. 2:2001;1010.
38. Akbari O., DeKruyff R.H., Umetsu D.T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol. 2:2001;725.
39. Menges M., Rossner S., Voigtlander C., et al. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med. 195:2002;15.
40. Ardavin C. Origin, precursors and differentiation of mouse dendritic cells. Nat Rev Immunol. 3:2003;582.
41. Reid S.D., Penna G., Adorini L. The control of T cell responses by dendritic cell subsets. Curr Opin Immunol. 12:2000;114.
42. Belz G.T., Behrens G.M., Smith C.M., et al. The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med. 196:2002;1099.
43. Grohmann U., Bianchi R., Orabona C., et al. Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. J Immunol. 171:2003;2581.
44. Hawiger D., Inaba K., Dorsett Y., et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med. 194:2001;769.
45. Adler A.J., Marsh D.W., Yochum G.S., et al. CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J Exp Med. 187:1998;1555.
46. Dhodapkar M.V., Steinman R.M. Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood. 100:2002;174.
47. Grohmann U., Fallarino F., Puccetti P. Tolerance, DCs and tryptophan much ado about IDO. Trends Immunol. 24:2003;242.
48. Mellor A.L., Munn D.H. Tryptophan catabolism and regulation of adaptive immunity. J Immunol. 170:2003;5809.
49. Munn D.H., Shafizadeh E., Attwood J.T., et al. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med. 189:1999;1363.
50. Fallarino F., Grohmann U., Vacca C., et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ. 9:2002;1069.
51. Grohmann U., Orabona C., Fallarino F., et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol. 3:2002;1097.
52. Gorczynski R.M., Hadidi S., Yu G., et al. The same immunoregulatory molecules contribute to successful pregnancy and transplantation. Am J Reprod Immunol. 48:2002;18.
53. Hwu P., Du M.X., Lapointe R., et al. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol. 164:2000;3596.
54. Fallarino F., Vacca C., Orabona C., et al. Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. Int Immunol. 14:2002;65.
55. Munn D.H., Sharma M.D., Lee J.R., et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science. 297:2002;1867.
56. Sakaguchi S., Sakaguchi N., Asano M., et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 155:1995;1151.
57. Wood K.J., Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol. 3:2003;199.
58. Shevach E.M. CD4+ CD25+ suppressor T cells more questions than answers. Nat Rev Immunol. 2:2002;389.
59. Finger E.B., Bluestone J.A. When ligand becomes receptor - tolerance via B7 signaling on DCs. Nat Immunol. 3:2002;1056.
60. Shimizu J., Yamazaki S., Takahashi T., et al. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol. 3:2002;135.
61. McHugh R.S., Whitters M.J., Piccirillo C.A., et al. CD4(+)CD25(+) immunoregulatory T cells gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 16:2002;311.
62. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:2003;1057.
63. Khattri R., Cox T., Yasayko S.A., et al. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol. 4:2003;337.
64. Bennett C.L., Christie J., Ramsdell F., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 27:2001;20.
65. Wildin R.S., Ramsdell F., Peake J., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 27:2001;18.
66. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 4:2003;330.
67. Hayday A., Tigelaar R. Immunoregulation in the tissues by gammadelta T cells. Nat Rev Immunol. 3:2003;233.
68. Sharif S., Arreaza G.A., Zucker P., et al. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med. 7:2001;1057.
69. Cosmi L, Liotta F, Lazzeri E, et al: Human CD8+CD25+ thymocytes sharing phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 2003
70. Chang C.C., Ciubotariu R., Manavalan J.S., et al. Tolerization of dendritic cells by T(S) cells the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol. 3:2002;237.
71. Wang R., Wang-Zhu Y., Grey H. Interactions between double positive thymocytes and high affinity ligands presented by cortical epithelial cells generate double negative thymocytes with T cell regulatory activity. Proc Natl Acad Sci U S A, 99:2002;2181.
72. Thornton A.M., Shevach E.M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol. 164:2000;183.
73. Klein L., Khazaie K., von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci U S A. 100:2003;8886.
74. Walker L.S., Chodos A., Eggena M., et al. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med. 198:2003;249.
75. Yamazaki S., Iyoda T., Tarbell K., et al. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med. 198:2003;235.
76. Fission S., Darrasse-Jeze G., Litvinova E., et al. Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J Exp Med. 198:2003;737.
77. Lohr J, Knoechel B, Jiang S, et al: The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nat Immunol 4:664, 2003
78. Hara M., Kingsley C.I., Niimi M., et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol. 166:2001;3789.
79. Fuss I.J., Boirivant M., Lacy B., et al. The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis. J Immunol. 168:2002;900.
80. Jonuleit H., Schmitt E., Kakirman H., et al. Infectious tolerance human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med. 196:2002;255.
81. Dieckmann D., Bruett C.H., Ploettner H., et al. Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact- independent type 1-like regulatory T cells [corrected]. J Exp Med. 196:2002;247.
82. Li X.C., Strom T.B., Turka L.A., et al. T cell death and transplantation tolerance. Immunity. 14:2001;407.
83. Lechler R.I., Garden O.A., Turka L.A. The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol. 3:2003;147.
84. Hutchings A., Wu J., Asiedu C., et al. The immune decision toward allograft tolerance in non-human primates requires early inhibition of innate immunity and induction of immune regulation. Transpl Immunol. 11:2003;335.
85. Salcido-Ochoa F., Lechler R.I. Dendritic cells prohibited by anergic T cells acquire tolerogenic properties. Transplant Proc. 34:2002;2851.
86. Wakkach A., Fournier N., Brun V., et al. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity. 18:2003;605.
87. Mahnke K., Qian Y., Knop J., et al. Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood. 101:2003;4862.
88. Min W.P., Zhou D., Ichim T.E., et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol. 170:2003;1304.
89. Germain R.N. The art of the probable system control in the adaptive immune system. Science. 293:2001;240.
90. Callard R., George A.J., Stark J. Cytokines, chaos, and complexity. Immunity. 11:1999;507.
91. Matthews J.B., Ramos E., Bluestone J.A. Clinical trials of transplant tolerance slow but steady progress. Am J Transplant. 3:2003;794.
92. Bonifaz L., Bonnyay D., Mahnke K., et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med. 196:2002;1627.
93. Mahnke K., Schmitt E., Bonifaz L., et al. Immature, but not inactive the tolerogenic function of immature dendritic cells. Immunol Cell Biol. 80:2002;477.
94. Manavalan J.S., Rossi P.C., Vlad G., et al. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl Immunol. 11:2003;245.
95. Buonocore S., Flamand V., Goldman M., et al. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft. Transplantation. 75:2003;407.
96. Zhang X., Izikson L., Liu L., et al. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J Immunol. 167:2001;4245.
97. Thorstenson K.M., Khoruts A. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol. 167:2001;188.
98. Chen Y., Kuchroo V.K., Inobe J., et al. Regulatory T cell clones induced by oral tolerance suppression of autoimmune encephalomyelitis. Science. 265:1994;1237.
99. Waldmann H., Cobbold S. How do monoclonal antibodies induce tolerance? A role for infectious tolerance? Annu Rev Immunol. 16:1998;619.
100. Wekerle T., Kurtz J., Bigenzahn S., et al. Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol. 14:2002;592.
101. Bushell A., Karim M., Kingsley C.I., et al. Pretransplant blood transfusion without additional immunotherapy generates CD25+CD4+ regulatory T cells a potential explanation for the blood-transfusion effect. Transplantation. 76:2003;449.
102. Lagaraine C., Lebranchu Y. Effects of immunosuppressive drugs on dendritic cells and tolerance induction. Transplantation. 75:2003;37S.
103. Levings M.K., Sangregorio R., Galbiati F., et al. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol. 166:2001;5530.
104. Groux H., O'Garra A., Bigler M., et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:1997;737.
105. Zheng S.G., Gray J.D., Ohtsuka K., et al. Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors. J Immunol. 169:2002;4183.
106. Yamagiwa S., Gray J.D., Hashimoto S., et al. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol. 166:2001;7282.
107. Rutella S., Pierelli L., Bonanno G., et al. Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood. 100:2002;2562.
108. Jiang S, Camara N, Lombardi G, et al: Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex-vivo. Blood 2003
109. Li Y., Li X.C., Zheng X.X., et al. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med. 5:1999;1298.
110. Kahan B.D. The limitations of calcineurin and mTOR inhibitors new directions for immunosuppressive strategies. Transplant Proc. 34:2002;130.
111. Vincenti P. Immunosuppression minimization current and future trends in transplant immunosuppression. J Am Soc Nephrol. 14:2003;1940.
112. Starzl T.E., Murase N., Abu-Elmagd K., et al. Tolerogenic immunosuppression for organ transplantation. Lancet. 361:2003;1502.
113. Rogers N.J., Lechler R.I. Allorecognition. Am J Transplant. 1:2001;97.
114. Ng W.F., Hernandez-Fuentes M., Baker R., et al. Reversibility with interleukin-2 suggests that T cell anergy contributes to donor-specific hyporesponsiveness in renal transplant patients. J Am Soc Nephrol. 13:2002;2983.
115. Game D.S., Hernandez-Fuentes M.P., Chaudhry A.N., et al. CD4+CD25+ regulatory T cells do not significantly contribute to direct pathway hyporesponsiveness in stable renal transplant patients. J Am Soc Nephrol. 14:2003;1652.
116. Salama A.D., Najafian N., Clarkson M.R., et al. Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol. 14:2003;1643.
117. Francois Bach J. Regulatory T cells under scrutiny. Nat Rev Immunol. 3:2003;189.
118. Ferrell J.E. Jr. Self-perpetuating states in signal transduction positive feedback, double-negative feedback and bistability. Curr Opin Cell Biol. 14:2002;140.
119. Tran H.M., Nickerson P.W., Restifo A.C., et al. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment. J Immunol. 159:1997;2232.